Incyte, Novartis to test repurposed cancer drug in COVID-19

The drugmakers, which are partnered on Incyte's therapy Jakafi, plan to quickly start Phase 3 trials in patients with inflammatory responses tied to COVID-19.

Apr 3, 2020 - 23:53
142 0
Incyte, Novartis to test repurposed cancer drug in COVID-19
The drugmakers, which are partnered on Incyte's therapy Jakafi, plan to quickly start Phase 3 trials in patients with inflammatory responses tied to COVID-19.
Read More